SH3GL2 and neoplasm: Several mechanisms have been reported to decrease SH3GL2 expression in tumor cells, including chromosomal deletion [173, 174, 181], promoter hypermethylation [174, 175, 179, 180], microRNA upregulation [170], and single nucleotide polymorphisms affecting transcript stability [182].